KNOTUS Co.Ltd (278650) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.083x

Based on the latest financial reports, KNOTUS Co.Ltd (278650) has a cash flow conversion efficiency ratio of -0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-9.34 Billion ≈ $-6.33 Million USD) by net assets (₩112.17 Billion ≈ $76.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

KNOTUS Co.Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how KNOTUS Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 278650 total liabilities for a breakdown of total debt and financial obligations.

KNOTUS Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of KNOTUS Co.Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Centrale d'Achat Française pour l'Outre-Mer Société Anonyme
PA:CAFO
0.140x
YEAH1 Group Corp
VN:YEG
-0.051x
DCM Corp
KO:024090
0.019x
SANU GOLD CORP.
F:L73
N/A
Income Opportunity Realty Investors
NYSE MKT:IOR
-0.001x
SEOHAN Const. & Eng.co.Ltd
KQ:011370
0.177x
Miko NV
BR:MIKO
0.072x
Muda Holdings Bhd
KLSE:3883
0.000x

Annual Cash Flow Conversion Efficiency for KNOTUS Co.Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of KNOTUS Co.Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of KNOTUS Co.Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩111.87 Billion
≈ $75.82 Million
₩-11.67 Billion
≈ $-7.91 Million
-0.104x -308.10%
2023-12-31 ₩103.57 Billion
≈ $70.19 Million
₩5.19 Billion
≈ $3.52 Million
0.050x -45.64%
2022-12-31 ₩70.28 Billion
≈ $47.63 Million
₩6.48 Billion
≈ $4.39 Million
0.092x -29.62%
2021-12-31 ₩64.59 Billion
≈ $43.77 Million
₩8.46 Billion
≈ $5.74 Million
0.131x -38.68%
2020-12-31 ₩53.64 Billion
≈ $36.35 Million
₩11.46 Billion
≈ $7.77 Million
0.214x +72.64%
2019-12-31 ₩41.86 Billion
≈ $28.37 Million
₩5.18 Billion
≈ $3.51 Million
0.124x -50.63%
2018-12-31 ₩20.67 Billion
≈ $14.01 Million
₩5.18 Billion
≈ $3.51 Million
0.251x -22.38%
2017-12-31 ₩16.04 Billion
≈ $10.87 Million
₩5.18 Billion
≈ $3.51 Million
0.323x -13.89%
2016-12-31 ₩8.36 Billion
≈ $5.66 Million
₩3.13 Billion
≈ $2.12 Million
0.375x --

About KNOTUS Co.Ltd

KQ:278650 Korea Biotechnology
Market Cap
$72.81 Million
₩107.45 Billion KRW
Market Cap Rank
#20422 Global
#1188 in Korea
Share Price
₩1272.00
Change (1 day)
-1.93%
52-Week Range
₩1099.00 - ₩1683.00
All Time High
₩36886.01
About

HLB bioStep Co.,Ltd. provides various test services in South Korea. It offers non clinical CRO services for cancer, bone and brain disease, endocrineand metabolic and eye disease, liver and circulatory system disease, dental and gastrointestinal disease, hair growth, kidney and respiratory disease, painmodel, and skin disease. It also offers representative analysis equipment, veterinary drug deve… Read more